Summary & Overview
CPT 90661: Intramuscular Trivalent Influenza Vaccine, 0.5 mL
CPT code 90661 denotes a 0.5 mL intramuscular trivalent influenza vaccine. As a widely used seasonal vaccine product, it supports public health efforts to reduce influenza-related morbidity and mortality across diverse patient populations. The code is relevant to clinicians, billing professionals, and payers because accurate coding affects vaccine coverage, claims processing, and public health reporting.
Key national payers considered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare and Medicare. Readers will find a concise overview of the clinical context for 90661, common billing considerations, and how major payers typically approach coverage and reimbursement for seasonal influenza immunizations. The publication highlights benchmarks for utilization and payment where available, notes relevant policy updates affecting vaccine coding and administration, and outlines typical sites of service for delivery.
This summary equips billing staff and policy analysts with the essential facts needed to code and classify intramuscular trivalent influenza vaccine services correctly, interpret payer coverage patterns, and understand the clinical setting in which 90661 is most commonly administered.
Billing Code Overview
CPT code 90661 describes an intramuscular influenza vaccine, trivalent, supplied as a 0.5 mL dose. The code represents administration of a vaccine product intended to protect against three influenza virus strains in a single season.
Service Type: Vaccine administration (intramuscular immunization)
Typical Site of Service: Outpatient clinics, physician offices, community health centers, and other ambulatory care settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 45-year-old adult presents to a primary care clinic during influenza season for routine immunization. The patient has no acute febrile illness and requests annual influenza vaccination. The clinician verifies vaccination history, screens for egg allergy and contraindications, documents informed consent, and administers the intramuscular 0.5 mL trivalent influenza vaccine (90661) in the deltoid. Observation for 15 minutes follows to monitor for immediate adverse reactions. Immunization record, lot number, manufacturer, site, and route are documented in the medical record and submitted for billing. Typical billing occurs under an outpatient office visit or immunization-only encounter at a primary care clinic, community health center, or occupational health setting.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when an E/M visit is distinct from vaccine administration and is medically necessary and documented |
59 | Distinct procedural service | Use to indicate a separate and distinct service when another procedure is performed the same day in a different anatomical site or is unrelated